Go Pro
OTCMKTS:EROX

Human Pheromone Sciences (EROX) Stock Price, News & Analysis

Human Pheromone Sciences logo
$0.0004 0.00 (0.00%)
As of 09/26/2022

About Human Pheromone Sciences Stock (OTCMKTS:EROX)

Key Stats

Today's Range
$0.0004
$0.0004
50-Day Range
N/A
52-Week Range
$0.00
$0.13
Volume
N/A
Average Volume
13,574 shs
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Human Pheromone Sciences, Inc., doing business as EROX, is a development‐stage company focused on the research, development and commercialization of consumer products based on human pheromone science. The company’s core business activity centers on formulating and marketing topical fragrances and perfumes that incorporate proprietary pheromone blends intended to enhance personal appeal. Its product lines are designed for direct‐to‐consumer sale through e‐commerce platforms and selected retail partnerships.

In addition to finished personal care products, Human Pheromone Sciences pursues formulation and licensing agreements that leverage its in-house expertise in volatile compound chemistry. The company holds or licenses patents and trademarks related to its pheromone delivery systems and works with contract manufacturers to ensure consistent quality and scalability. While still in early stages of market penetration, EROX aims to expand its portfolio beyond fragrances into adjacent wellness categories that utilize pheromone technology.

Headquartered in Delaware, Human Pheromone Sciences currently serves primarily the North American market but has indicated plans to explore distribution channels in Europe and Asia as part of its longer-term growth strategy. Although publicly traded on the OTC Pink market under the ticker EROX, detailed information on executive leadership and financial metrics remains limited. As a niche player in the personal care sector, the company continues to develop both its research pipeline and consumer-facing brands in pursuit of broader market adoption.

AI Generated. May Contain Errors.

Receive EROX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Human Pheromone Sciences and its competitors with MarketBeat's FREE daily newsletter.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

EROX Stock News Headlines

No headlines for this company have been tracked by MarketBeat.com

EROX Stock Analysis - Frequently Asked Questions

Human Pheromone Sciences' stock was trading at $0.0004 at the beginning of the year. Since then, EROX shares have increased by 0.0% and is now trading at $0.0004.

Shares of EROX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Company Calendar

Today
8/17/2026
Fiscal Year End
12/31/2026

Industry, Sector and Symbol

Stock Exchange
OTCMKTS
Industry
Toilet Preparations
Sub-Industry
N/A
Current Symbol
OTCMKTS:EROX
CIK
N/A
Employees
3
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
N/A
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
N/A
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
N/A
Return on Assets
N/A

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
N/A
Quick Ratio
N/A

Sales & Book Value

Annual Sales
N/A
Price / Sales
N/A
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
N/A
Price / Book
N/A

Miscellaneous

Outstanding Shares
N/A
Free Float
N/A
Market Cap
N/A
Optionable
Not Optionable
Beta
3.30
Options Trading Made Easy - Download Now Cover

Learn the basics of options trading and how to use them to boost returns and manage risk with this free report from MarketBeat. Click the link below to get your free copy.

Get This Free Report

This page (OTCMKTS:EROX) was last updated on 8/17/2026 by MarketBeat.com Staff.
From Our Partners